Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Differential expression of metallothioneins in human prion diseases.

Differential expression of metallothioneins in human prion diseases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Differential expression of metallothioneins in human prion diseases. Abstract Text:

    t kawashimaT Kawashima,k doh-uraK Doh-ura,m torisuM Torisu,y uchidaY Uchida,a furutaA Furuta,t iwakiT Iwaki,

    We herein report an immunohistochemical and a Western blot analysis on metal/free radical chelating proteins, metallothioneins (MTs; MT-I/II and MT-III), in the brains of human prion disease patients with or without prion protein gene mutation and polymorphism. Irrespective of the isoforms of MTs, the immunoreaction was detected in the cytoplasm and processes of the astrocytes in the cerebral cortex and white matter in normal controls and prion disease brains. Although the immunoreactivities for MTs in Creutzfeldt-Jakob disease (CJD) brains varied from case to case, they were generally dependent upon the disease duration. In CJD patients with a relatively long disease course, the immunoreaction for both MT-I/II and MT-III in the astrocytes was significantly reduced, and this finding was not modified by the genotypes of the patients. On the other hand, in patients with Gerstmann-Sträussler-Scheinker syndrome, MT-I/II immunoreactivity in the astrocytes was exclusively reduced, while the immunoreaction for MT-III was relatively well preserved. Especially the astrocytes in the vicinities of the kuru plaques exhibited a weak or no immunoreaction even for MTs but a strong immunoreaction for glial fibrillary acidic protein. A quantitative Western blot analysis also revealed that MT-I/II protein accumulated in CJD brain with a short disease duration, whereas MT-III in CJD brain with a long disease duration was statistically significantly reduced in comparison to the normal brains. These findings suggest that the protein expression of MTs in the astrocytes is thus regulated differentially among human prion diseases and modified locally by such abnormal prion protein depositions as kuru plaques.

    Differential expression of metallothioneins in human prion diseases. Publishing Authors By Initials

    t kawashimaT Kawashima,k doh-uraK Doh-ura,m torisuM Torisu,y uchidaY Uchida,a furutaA Furuta,t iwakiT Iwaki,

    For similar proteins: prions research abstracts see: proteins: prions research

    PUBMED ID PMID:

    MEDLINE DATE: 2000 Sep-Oct

    Differential expression of metallothioneins in human prion diseases. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Dementia and geriatric cognitive disorders

    VOLUME: 11

    Page Numbers: 251-62

    Journal Abbreviation: Dement Geriatr Cogn Disord

    ISSN: 1420-8008

    DAY: 24

    MONTH: 03

    YEAR: 2008

    Differential expression of metallothioneins in human prion diseases. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9705200

    Differential expression of metallothioneins in human prion diseases. Keywords Mesh Terms:

    KEYWORDS: Prions

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Differential expression of metallothioneins in human prion diseases. Information

    Substance Name: Metallothionein

    Registry Number: 9038-94-2

    Grant and Affiliation Information for Differential expression of metallothioneins in human prion diseases.

    AFFILIATION: Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. toshiro@npsych.med.kyushu-u.ac.jp

    Country: SWITZERLAND

    SWITZERLAND Research PublicationSWITZERLAND Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Dement Geriatr Cogn Disord

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Differential expression of metallothioneins in human prion diseases Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News